U.S. flag

An official website of the United States government

NM_000251.3(MSH2):c.367-2_645+432del AND Lynch syndrome

Germline classification:
Pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001355861.1

Allele description [Variation Report for NM_000251.3(MSH2):c.367-2_645+432del]

NM_000251.3(MSH2):c.367-2_645+432del

Gene:
MSH2:mutS homolog 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_000251.3(MSH2):c.367-2_645+432del
HGVS:
  • NC_000002.12:g.47410092_47410804del
  • NG_007110.2:g.11969_12681del
  • NM_000251.3:c.367-2_645+432delMANE SELECT
  • NM_001258281.1:c.169-2_447+432del
  • LRG_218:g.11969_12681del
  • NC_000002.11:g.47637231_47637943del
Links:
dbSNP: rs2104016448
NCBI 1000 Genomes Browser:
rs2104016448
Molecular consequence:
  • NM_000251.3:c.367-2_645+432del - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001258281.1:c.169-2_447+432del - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_000251.3:c.367-2_645+432del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001258281.1:c.169-2_447+432del - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Lynch syndrome
Identifiers:
MONDO: MONDO:0005835; MedGen: C4552100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001550867Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Pathogenicunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001550867.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.367-?_1076+?del deletion variant encompassing exons 3-6 has been previously reported in the literature in at least 3 of 631 proband chromosomes in individuals who either met criteria for Lynch syndrome or had colorectal or endometrial cancer (Becouarn 2005, Grabowski 2005, Kurzawski 2006, Pastrello 2006, Pistorius 2006). In one study, co-segregation with disease and "contiguous exons" by RT/PCR was noted (Kurzawski 2006). This variant was also reported in the HGMD, UMD, MisMatch Repair (Memorial University), and Insight (LOVD) databases. Note, the precise breakpoints for this deletion were not determined. However, the variant is predicted to cause a frameshift and to lead to a premature stop codon. This alteration may result in a truncated or absent protein product and loss of function. Loss of function variants of the MSH2 gene are an established mechanism of disease in Lynch syndrome. In summary, based on the above information, this variant meets our criteria to be classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023